Design Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Design Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Design Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Design Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $551k | 89k | 6.17 |
| 2024-09-30 | $219k | 41k | 5.38 |
| 2024-06-30 | $48k | 14k | 3.35 |
| 2024-03-31 | $156k | 39k | 4.03 |
| 2023-12-31 | $109k | 41k | 2.65 |
| 2023-09-30 | $133k | 56k | 2.36 |
| 2023-06-30 | $328k | 52k | 6.30 |
| 2023-03-31 | $150k | 26k | 5.78 |
| 2022-12-31 | $0 | 20k | 0.00 |
| 2022-06-30 | $211k | 18k | 11.56 |
| 2022-03-31 | $326k | 20k | 16.12 |
| 2021-12-31 | $337k | 16k | 21.39 |